Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025

Largest global clinical trial in pediatric myopia met primary efficacy endpoint of proportion of patients with confirmed progression of -0.75D and key secondary endpoint of annual progression rate Treatment effects evident by month 12 and sustained through month 36; greatest treatment benefit observed in younger children, in participants with a history of myopia progression, or when administered […]

Social Media

Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025

Co-Founder & Co-CEO, Marketing & Brand Experience

Jenna is passionate about advancing patient access to advanced healthcare innovations and leveraging her significant experience in marketing and brand development in service of that passion. With over 15 years of medical device marketing experience in ophthalmology and bariatrics, she specializes in global commercialization, product launches, clinical trial patient recruitment, branding, messaging, internet marketing strategies, and developing comprehensive marketing assets to support growth initiatives.

Prior to co-founding LaunchLab Partners, Jenna led Global Marketing for AcuFocus, a privately held medical device company based in Southern California. At AcuFocus she spearheaded the company’s global marketing strategy and led execution of the company’s brand and market development initiatives, launching first-of-their-kind products.

Jenna holds a B.A. in Marketing from San Diego State University and a certificate in Advanced Digital Marketing Growth strategies from the Wharton School of the University of Pennsylvania. She also serves as a digital ambassador for the Ophthalmic World Leaders (OWL) and is a member of Women in Ophthalmology.

A self-identified Peloton enthusiast (#BeKindGoFarr), Jenna is committed to action, growth, community, and achievement.